TEXAS HEALTH HEART & VASCULAR HOSP — History
CCN 670071 | 3-year financial timeline | COVID resilience: 32/100
🛡️ Public data only — no PHI permitted on this instance.
$48M
Latest Revenue (FY2022)
-0.9%
Revenue CAGR (3yr)
-7.1%
Financial Timeline
| Metric | FY2020 | FY2021 | FY2022 | YoY (Latest) | CAGR |
|---|---|---|---|---|---|
| Net Patient Revenue | $48M | $54M | $48M | -11.6% | -0.9% |
| Operating Expenses | $46M | $50M | $51M | +2.6% | +5.0% |
| Operating Margin | 4.6% | 7.7% | -7.1% | -191.7% | +0.0% |
| Net Income | $2M | $4M | $-3M | -181.1% | +0.0% |
| Licensed Beds | 47 | 47 | 47 | +0.0% | +0.0% |
| Total Patient Days | 4,237 | 4,558 | 3,871 | -15.1% | -4.4% |
| Medicare Day % | 31% | 31% | 31% | -1.0% | -0.7% |
| Medicaid Day % | 1% | 0% | 1% | +126.4% | -18.3% |
COVID Impact & Recovery
Resilience Score: 32/100 — Distressed — significant COVID damage
Revenue recovery from FY2020 to FY2022: -1.8% ($48M → $48M)
FY2020 captured the initial COVID shock. Slow recovery suggests structural challenges beyond COVID.
Trend Summary
Revenue▶ Stable
Operating Margin▼ Declining
Beds▶ Stable
Medicare Mix▲ Growing
vs State Average ()
Revenue Growth
-0.9%
This Hospital
+7.6%
State Avg
Latest Margin
-7.1%
This Hospital
-4.6%
State Avg
Projections (FY2023-2025)
Extrapolated from 3-year trend using linear projection. Does not account for regulatory or market changes.
| Year | Revenue (proj) | Margin (proj) |
|---|---|---|
| FY2023 (proj) | $47M | -12.9% |
| FY2024 (proj) | $47M | -18.7% |
| FY2025 (proj) | $46M | -24.6% |